The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 clinical trial of autologous T-cells genetically engineered with a chimeric receptor to target the follicle-stimulating hormone receptor (FSHR) in recurrent ovarian cancer (OVCA).
 
Robert Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Seagen; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; Immunogen; Legend Biotech; Merck; Mersana; Regeneron; Seattle Genetics/Astellas; Sonnet; Sonnet; Tesaro
Speakers' Bureau - Curio Science; OncLive/MJH Life Sciences
Research Funding - Anixa Biosciences (Inst); Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - Eisai
Other Relationship - AstraZeneca; GlaxoSmithKline/Tesaro
 
Marco Davila
Stock and Other Ownership Interests - A2 Biotherapeutics; Adaptive Biotechnologies; Adicet Bio; Precision Biosciences
Consulting or Advisory Role - Lyell Immunopharma
Speakers' Bureau - Bristol-Myers Squibb/Celgene/Juno; Kite, a Gilead company
Research Funding - crispr therapeutics
 
Daniel Abate-Daga
(OPTIONAL) Uncompensated Relationships - Anixa Biosciences
 
Melissa McGettigan
No Relationships to Disclose
 
Xuefeng Wang
No Relationships to Disclose
 
Theresa Boyle
Honoraria - Bristol Meyers Squibb
Research Funding - Bristol Meyers Squibbs
 
Pamela Garzone
Employment - Anixa Biosciences
Leadership - Anixa Biosciences
Stock and Other Ownership Interests - Anixa Biosciences
 
Amit Kumar
Employment - Anixa Biosciences
Leadership - Anixa Biosciences
Stock and Other Ownership Interests - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Numerous patents at Harvard University, Anixa Biosciences
 
Denise Dorman
No Relationships to Disclose
 
Richard Koya
Stock and Other Ownership Interests - Coastar (I); Tactiva Therapeutics
Consulting or Advisory Role - Zoll
Research Funding - TERUMO
Patents, Royalties, Other Intellectual Property - Roswell Park Cancer Center
 
Jose Conejo-Garcia
Research Funding - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Moffitt Cancer Center